Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vytorin vs Atorvastatin in Hypercholesterolemia and CAD
NCT00442897Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Sep 2006
- Primary completion
- Oct 2008
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
01
Overview
Phase 4, randomised, double-blind trial of Vytorin in hypercholesterolemia (2 arms), sponsored by Organon & Co. Primary endpoint: Number of Participants Reaching the LDL-C Goal (< 100 mg/dl) After 6 Weeks of Treatment. Started Sep 2006; status: completed.
02
Drugs
Vytorin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00442897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442897.